Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia
Victoria P. Tan(Queen Mary Hospital), Wai K. Leung(Chinese University of Hong Kong), Frank Y.F. Lam(Astellas Pharma (Japan)), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), K. S. H. Liu(Queen Mary Hospital)
Cited by 141
Related Papers
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
|Gastroenterology|2020|1.7k
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
|Clinical Infectious Diseases|2020|818
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
|Clinical Infectious Diseases|2011|716